Checkpoint Therapeutics to Present at the Virtual Fortress Biotech R&D Summit Hosted by B. Riley Securities Apr 04, 2022
Mustang Bio to Present at the Virtual Fortress Biotech R&D Summit Hosted by B. Riley Securities Apr 04, 2022
Fortress Biotech Announces Virtual Two-Day R&D Summit Hosted by B. Riley Securities on Tuesday, April 5 and Wednesday, April 6, 2022 Apr 01, 2022
Checkpoint Therapeutics Reports Full-Year 2021 Financial Results and Recent Corporate Highlights Mar 28, 2022
Journey Medical Corporation Reports Full-Year 2021 Financial Results and Recent Corporate Highlights Mar 23, 2022
Fortress Biotech, Cyprium Therapeutics and Sentynl Therapeutics Announce CUTX-101, Copper Histidinate, Data to be Presented at 2022 American College of Medical Genetics Annual Clinical Genetics Meeting Mar 21, 2022
Journey Medical Corporation to Release Year End 2021 Financial Results and Provide Corporate Update on March 23, 2022 Mar 18, 2022
Journey Medical Corporation Announces First Patient Dosed in Phase 3 Clinical Trial Evaluating DFD-29 (Minocycline Modified Release Capsules 40 mg) for the Treatment of Rosacea Mar 17, 2022
